1
|
Abdel-Razek O, Marbach JA, Simard T, Almufleh A, Di Santo P, Jung R, Parlow S, Mathew R, Hibbert B, Froeschl M. Formalized Research Training Increases Fellowship and Early Career Academic Productivity: A Five-Year Follow-up. Can J Cardiol 2023; 39:1310-1312. [PMID: 37149217 DOI: 10.1016/j.cjca.2023.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 04/26/2023] [Accepted: 04/30/2023] [Indexed: 05/08/2023] Open
Affiliation(s)
- Omar Abdel-Razek
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
| | - Jeffrey A Marbach
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Knight Cardiovascular Center, Division of Cardiovascular Medicine, Oregon Health and Science University, Portland, Oregon, USA
| | - Trevor Simard
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
| | - Aws Almufleh
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, Queens University, Kingston, Ontario, Canada
| | - Pietro Di Santo
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; Department of Medicine, Division of Critical Care, University of Ottawa, Ottawa, Ontario, Canada
| | - Richard Jung
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - Simon Parlow
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Medicine, Division of Critical Care, University of Ottawa, Ottawa, Ontario, Canada
| | - Rebecca Mathew
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
| | - Benjamin Hibbert
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
| | - Michael Froeschl
- CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
| |
Collapse
|
2
|
Pacheco C, Tremblay-Gravel M, Marquis-Gravel G, Couture E, Avram R, Desplantie O, Bibas L, Simard F, Malhamé I, Poulin A, Tran D, Senechal M, Afilalo J, Farand P, Bérubé L, Jolicoeur E, Ducharme A, Tournoux F. Association between Right Ventricular Dysfunction and Adverse Outcomes in Peripartum Cardiomyopathy: Insights from the retrospective BRO-HF Quebec Cohort Study. CJC Open 2022; 4:913-920. [DOI: 10.1016/j.cjco.2022.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 05/10/2022] [Indexed: 10/18/2022] Open
|
3
|
Tremblay-Gravel M, Marquis-Gravel G, Avram R, Desplantie O, Ducharme A, Bibas L, Pacheco C, Couture E, Simard F, Poulin A, Malhamé I, Tran D, Rey E, Tournoux F, Harvey L, Sénéchal M, Bélisle P, Descarries L, Farand P, Pranno N, Diaz A, Afilalo J, Ly HQ, Fortier A, Jolicoeur EM. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study. ESC Heart Fail 2018; 6:27-36. [PMID: 30565890 PMCID: PMC6351886 DOI: 10.1002/ehf2.12376] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2018] [Revised: 08/29/2018] [Accepted: 10/10/2018] [Indexed: 11/22/2022] Open
Abstract
Aims Bromocriptine is thought to facilitate left ventricular (LV) recovery in peripartum cardiomyopathy (PPCM) through inhibition of prolactin secretion. However, this potential therapeutic effect remains controversial and was incompletely studied in diverse populations. Methods and results Consecutive women with new‐onset PPCM (n = 76) between 1994 and 2015 in Quebec, Canada, were classified according to treatment (n = 8, 11%) vs. no treatment (n = 68, 89%) with bromocriptine. We assessed LV functional recovery at mid‐term (6 months) and long‐term (last follow‐up) and compared outcomes among groups. Women treated with bromocriptine experienced better mid‐term left ventricular ejection fraction (LVEF) recovery from 23 ± 10% at baseline to 55 ± 12% at 6 months, compared with a change from 30 ± 12% at baseline to 45 ± 13% at 6 months in women treated with standard medical therapy (P interaction < 0.01). At long‐term, a similar positive association was found with bromocriptine (9% greater LVEF variation, P interaction < 0.01). In linear regressions adjusted for obstetrical, clinical, echocardiographic, and pharmacological variables, treatment with bromocriptine was associated with a greater improvement in LVEF [β coefficient (standard error), 14.1 (4.4); P = 0.03]. However, there was no significant association between bromocriptine use and the combined occurrence of all‐cause death and heart failure events (hazard ratio, 1.18; 95% confidence interval, 0.15 to 9.31), using univariable Cox regressions based over a cumulative follow‐up period of 285 patient‐years. Conclusions In women newly diagnosed with PPCM, treatment with bromocriptine was independently associated with greater LV functional recovery.
Collapse
Affiliation(s)
| | | | - Robert Avram
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | - Olivier Desplantie
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | - Anique Ducharme
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | | | - Christine Pacheco
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | - Etienne Couture
- Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, Sherbrooke, Canada
| | - François Simard
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | - Anthony Poulin
- Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Canada
| | | | - Dan Tran
- Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Canada
| | - Evelyne Rey
- Hôpital Sainte-Justine, University of Montreal, Montreal, Canada
| | - François Tournoux
- Centre Hospitalier Universitaire de Montréal, University of Montreal, Montreal, Canada
| | - Luc Harvey
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | - Mario Sénéchal
- Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Canada
| | - Pierre Bélisle
- Hôpital de Chicoutimi, University of Sherbrooke, Saguenay, Canada
| | | | - Paul Farand
- Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, Sherbrooke, Canada
| | - Nicolas Pranno
- Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Canada
| | - Ariel Diaz
- Centre Hospitalier Affilié Universitaire Régional de Trois-Rivières, University of Montreal, Trois-Rivières, Canada
| | | | - Hung Q Ly
- Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
| | - Annik Fortier
- Montreal Health Innovations Coordinating Center, University of Montreal, Montreal, Canada
| | | | | |
Collapse
|
4
|
Avram R, Marquis-Gravel G, Simard F, Pacheco C, Couture É, Tremblay-Gravel M, Desplantie O, Malhamé I, Bibas L, Mansour S, Parent MC, Farand P, Harvey L, Lessard MG, Ly H, Liu G, Hay AE, Marc Jolicoeur E. Understanding the patient perspective on research access to national health records databases for conduct of randomized registry trials. Int J Cardiol 2018; 262:110-116. [PMID: 29706388 DOI: 10.1016/j.ijcard.2017.12.074] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/08/2017] [Revised: 11/02/2017] [Accepted: 12/20/2017] [Indexed: 01/01/2023]
Abstract
BACKGROUND Use of health administrative databases is proposed for screening and monitoring of participants in randomized registry trials. However, access to these databases raises privacy concerns. We assessed patient's preferences regarding use of personal information to link their research records with national health databases, as part of a hypothetical randomized registry trial. METHODS AND RESULTS Cardiology patients were invited to complete an anonymous self-reported survey that ascertained preferences related to the concept of accessing government health databases for research, the type of personal identifiers to be shared and the type of follow-up preferred as participants in a hypothetical trial. A total of 590 responders completed the survey (90% response rate), the majority of which were Caucasians (90.4%), male (70.0%) with a median age of 65years (interquartile range, 8). The majority responders (80.3%) would grant researchers access to health administrative databases for screening and follow-up. To this end, responders endorsed the recording of their personal identifiers by researchers for future record linkage, including their name (90%), and health insurance number (83.9%), but fewer responders agreed with the recording of their social security number (61.4%, p<0.05 with date of birth as reference). Prior participation in a trial predicted agreement for granting researchers access to the administrative databases (OR: 1.69, 95% confidence interval: 1.03-2.90; p=0.04). CONCLUSION The majority of Cardiology patients surveyed were supportive of use of their personal identifiers to access administrative health databases and conduct long-term monitoring in the context of a randomized registry trial.
Collapse
Affiliation(s)
- Robert Avram
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - Guillaume Marquis-Gravel
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - François Simard
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - Christine Pacheco
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - Étienne Couture
- Centre Hospitalier Universitaire de Sherbrooke, Cardiology, Sherbrooke, Quebec, Canada; Université de Sherbrooke, Cardiology, Sherbrooke, Québec, Canada
| | - Maxime Tremblay-Gravel
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - Olivier Desplantie
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | | | - Lior Bibas
- McGill University, Cardiology, Montreal, Québec, Canada
| | - Samer Mansour
- Centre Hospitalier Universitaire de Montréal - Hôtel Dieu Hospital, Montreal, Québec, Canada
| | - Marie-Claude Parent
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - Paul Farand
- Centre Hospitalier Universitaire de Sherbrooke, Cardiology, Sherbrooke, Quebec, Canada; Université de Sherbrooke, Cardiology, Sherbrooke, Québec, Canada
| | - Luc Harvey
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada
| | | | - Hung Ly
- Montreal Heart Institute, Cardiology, Montréal, Québec, Canada; Université de Montréal, Cardiology, Montréal, Québec, Canada
| | - Geoffrey Liu
- University Hospital Network, Toronto, Ontario, Canada
| | - Annette E Hay
- Queen's University, Canadian Cancer Trials Group, Kingston, Ontario, Canada; Queen's University, Department of Medicine, Kingston, Ontario, Canada
| | | |
Collapse
|
5
|
Simard P, Massie C, Ieroncig F, Demers SP, Marquis-Gravel G. Nuts and Bolts of Scientific Authorship: Doing It Right. Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
6
|
Marquis-Gravel G, Ghersi I, Boivin-Proulx LA, Verreault-Julien L, Alansari Y, Ieroncig F, Demers SP. The Ongoing Quest for Optimal Thrombus Prevention After ST-Elevation Myocardial Infarction in the Modern Era. Can J Cardiol 2018; 34:93.e3. [DOI: 10.1016/j.cjca.2017.10.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Revised: 10/31/2017] [Accepted: 10/31/2017] [Indexed: 10/18/2022] Open
|